Rankings
▼
Calendar
ZTS Q2 2016 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena
ZTS
Zoetis Inc.
$53B
Q2 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.2B
Gross Profit
$809M
67.0% margin
Operating Income
$356M
29.5% margin
Net Income
$224M
18.5% margin
EPS (Diluted)
$0.45
QoQ Revenue Growth
+4.0%
Cash Flow
Operating Cash Flow
$137M
Free Cash Flow
$83M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$7.5B
Total Liabilities
$6.1B
Stockholders' Equity
$1.4B
Cash & Equivalents
$658M
Revenue Segments
Dogs and Cats
$487M
41%
Cattle
$366M
31%
Swine
$150M
13%
Poultry
$118M
10%
Fish
$39M
3%
Horses
$36M
3%
Geographic Segments
International
$602M
50%
UNITED STATES
$594M
50%
← FY 2016
All Quarters
Q3 2016 →